阿托伐他汀对高血压肾脏并发症炎性损伤的治疗作用(英文)

通过考察阿托伐他汀(atorvastatin, ATO) 对自发性高血压大鼠(spontaneously hypertensive rats, SHR) 肾脏炎性损害的影响, 探讨了 ATO 对高血压肾脏并发症的防治作用。将4周龄SHR分为高血压模型组和ATO治疗组(8mg/kg),以同周龄的Wistar-Kyoto大鼠为正常对照。灌胃给药8周后, 采用酶联免疫法(enzyme linked immunosorbent assay)测定血浆和肾组织血管紧张素Ⅱ(angiotensin, AngⅡ)含量;测定诱导性一氧化氮合酶(inducible nitric oxide synthase, iNOS)及细胞间粘附分子-1(intercellular adhesion molecule-1, ICAM-1) 的蛋白表达和亚硝酸阴离子(nitrite, NO2-)含量,以评价肾脏炎症状态; 以苏木素伊红(hematoxylin and eosin)和过碘酸六胺银染色(periodic acid-silver metheramine) 染色示SHR肾小球和肾间质形态学病变,并以尿蛋白含量为指标衡量肾脏功能。结果显示...     

Association of TERC and OBFC1 Haplotypes with Mean Leukocyte Telomere Length and Risk for Coronary Heart Disease

Objective

To replicate the associations of leukocyte telomere length (LTL) with variants at four loci and to investigate their associations with coronary heart disease (CHD) and type II diabetes (T2D), in order to examine possible causal effects of telomere maintenance machinery on disease aetiology.

Methods

Four SNPs at three loci BICD1 (rs2630578 GγC), 18q12.2 (rs2162440 GγT), and OBFC1 (rs10786775 CγG, rs11591710 AγC) were genotyped in four studies comprised of 2353 subjects out of which 1148 had CHD and 566 T2D. Three SNPs (rs12696304 CγG, rs10936601G>T and rs16847897 GγC) at the TERC locus were genotyped in these four studies, in addition to an offspring study of 765 healthy students. For all samples, LTL had been measured using a real-time PCR-based method.

Results

Only one SNP was associated with a significant effect on LTL, with the minor allele G of OBFC1 rs10786775 SNP being associated with longer LTL (β=0.029, P=0.04). No SNPs were significantly associated with CHD or T2D. For OBFC1 the haplotype carrying both rare alleles (rs10786775G and rs11591710C, haplotype frequency 0.089) was associated with lower CHD prevalence (OR: 0.77; 95% CI: 0.61–0.97; P= 0.03). The TERC haplotype GTC (rs12696304G, rs10936601T and rs16847897C, haplotype frequency 0.210) was associated with lower risk for both CHD (OR: 0.86; 95% CI: 0.75-0.99; P=0.04) and T2D (OR: 0.74; 95% CI: 0.61–0.91; P= 0.004), with no effect on LTL. Only the last association remained after adjusting for multiple testing.

Conclusion

Of reported associations, only that between the OBFC1 rs10786775 SNP and LTL was confirmed, although our study has a limited power to detect modest effects. A 2-SNP OBFC1 haplotype was associated with higher risk of CHD, and a 3-SNP TERC haplotype was associated with both higher risk of CHD and T2D. Further work is required to confirm these results and explore the mechanisms of these effects.     

Anti–coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin

The present study aimed to uncover the pharmacological function and underlying mechanism of puerarin as a potential treatment for COVID-19, using an in silico methodology, including network pharmacology and molecular docking. The pivotal targets of puerarin to treat COVID-19 were identified and included the epidermal growth factor receptor (EGFR), tumour necrosis factor (TNF), tumour protein p53 (TP53), caspase 3 (CASP3), RELA proto-oncogene (RELA), Fos proto-oncogene (FOS), caspase 8 (CASP8), prostaglandin-endoperoxide synthase 2 (PTGS2), interleukin 2 (IL2), protein kinase CB (PRKCB), B cell lymphoma/leukaemia gene-2 (BCL2), protein kinase CA (PRKCA), nitric oxide synthase 3 (NOS3) and peroxisome proliferator–activated receptor gamma (PPARG). Functionally, the anti–COVID-19 action of puerarin was associated with the suppression of oxidative stress and inflammatory cascades, and cell apoptosis. The signalling pathways of puerarin to treat COVID-19 included modulation of the pathways of apoptosis, IL-17 signalling, mitogen-activated protein kinase (MAPK) signalling and TNF signalling. Molecular docking data illustrated the binding capacity of puerarin with COVID-19 and the effective anti–COVID-19 activity of puerarin. Taken together, our current network pharmacology–based findings revealed the pharmacological role of puerarin in the treatment of COVID-19. Furthermore, the bioinformatic findings elucidated that some of these pivotal targets might serve as potential molecular markers for detecting COVID-19.     

Prediction Factors of Recurrent Ischemic Events in One Year after Minor Stroke

Background

The risk of a subsequent stroke following a minor stroke is high. However, there are no effective rating scales to predict recurrent stroke following a minor one. Therefore, we assessed the risk factors associated with recurrent ischemic stroke or transient ischemic attack (TIA) within one year of minor stroke onset in order to identify possible risk factors.

Methods

Eight hundred and sixty-three non-cardioembolic ischemic stroke patients in the Chinese IntraCranial AtheroSclerosis Study that presented with minor stroke, defined as an admission National Institutes of Health stroke scale (NIHSS) score of ≤3, were consecutively enrolled in our study. Clinical information and imaging features upon admission, and any recurrent ischemic stroke or TIA within one year was recorded. Cox regression was used to identify risk factors associated with recurrent ischemic stroke or TIA within the year following stroke onset.

Results

A total of 50 patients (6.1%) experienced recurrent ischemic stroke or TIA within one year of minor stroke onset. Multivariate Cox regression model identified lower admission NIHSS score (HR, 1.75; 95% CI, 1.32 to 2.33; P<0.0001), history of coronary heart disease (HR, 2.62; 95% CI, 1.17 to 5.86; P = 0.02), severe stenosis or occlusion of large cerebral artery (HR, 4.68; 95% CI, 1.87 to 11.7; P = 0.001), and multiple acute cerebral infarcts (HR, 2.61; 95% CI, 1.01 to 6.80; P = 0.05) as independent risk factors for recurrent ischemic stroke or TIA within one year.

Conclusions

Some minor stroke patients are at higher risk for recurrent ischemic stroke or TIA. Urgent and intensified therapy may be reasonable in these patients.     

Element fluxes in watershed-lake ecosystems recovering from acidification: Plešné Lake,the Bohemian Forest, 2001–2005

Fluxes of major ions and nutrients were measured in the watershed-lake ecosystem of a strongly acidified lake, Ple?né jezero (Ple?né Lake), in the Czech Republic in hydrological years from 2001 through 2005. The lake is situated in a Norway spruce forest and has a steep watershed between elevations of 1090 and 1378 m. The average water input and output from the ecosystem was 1372 mm and 1157 mm (37 L km^?2 s^?1), respectively, and the water residence time averaged 306 days. Despite ecosystem recovery from acidification occurring since the late 1980s, the Ple?né watershed was an average net source of 25 mmol SO ₄ ^2? m^?2 yr^?1. Nitrogen saturation of the watershed caused low retention of the deposited inorganic N (< 44% on average) before 2004. Then, the watershed became a net source of 28–32 mmol m^?2 yr^?1 of inorganic N in the form of NO ₃ ^? due to climatic effects (a dry summer in 2003 and a cold winter in 2004) and forest dieback caused by a bark beetle attack in 2004. Nitrogen transformations and SO ₄ ^2? release were the dominant terrestrial sources of H⁺ (72 and 49 mmol m^?2 yr^?1, respectively) and the watershed was a net source of 24 mmol H⁺ m^?2 yr^?1. Ionic composition of surface inlets showed seasonal variations, with the most pronounced changes in NO ₃ ^? , ionic Al (Al_i), and DOC concentrations, while the composition of subsurface inlets was more stable. The in-lake biogeochemical processes reduced on average 59% of the incoming H⁺ (251 mmol H⁺ m^?2 yr^?1 on a lake-area basis). NO ₃ ^? assimilation and denitrification, photochemical and microbial decomposition of allochthonous organic acids, and SO ₄ ^2? reduction in the sediments were the most important aquatic H⁺ consuming processes (358, 121, and 59 mmol H⁺ m^?2 yr^?1, respectively), while hydrolysis of Al_i was the dominant in-lake H⁺ generating process (233 mmol H⁺ m^?2 yr^?1). Photochemical liberation from organic complexes was an additional in-lake source of Al_i. The net in-lake retention or removal of total phosphorus, total nitrogen, and silica were on average 50%, 27%, and 23%, respectively. The lake was a net source of NH ₄ ⁺ due to a cease in nitrification (pH < 5) and from NH ₄ ⁺ production by dissimilation exceeding its removal by assimilation.     

A simple method for selection of trypsin chromogenic substrates using combinatorial chemistry approach

A tetrapeptide combinatorial library, considered as chromogenic substrates of bovine beta-trypsin, was synthesized by the solid phase method. The peptides contain an analog of p-nitroanilide, obtained by attaching 5-amino-2-nitrobenzoic acid (Anb(5,2)) to the C-termini. Deconvolution of the peptide library, performed in solution using an iterative method, yielded four efficient trypsin substrates. The most active one, Phe-Val-Pro-Arg-Anb(5,2)-NH(2), appeared to be 125-fold more active than Bz-D,L-Arg-pNA (BAPNA) used as a reference compound. The reported method of designing trypsin chromogenic substrate libraries is straightforward. Such p-nitroanilides may be useful for the investigation of any protease substrate specificity.     

消化道氮能神经的研究进展

人体消化道的神经构成复杂、功能多样,向来是学术界的研究热点之一。与其相关的新观点、新概念、新物质的报道层出不穷。20世纪末期,基于对一氧化氮(NO)生物学作用广泛而深入地研究,人们发现并明确了NO是一种新型神经递质。由于此类以NO为递质的神经具有重要的生物学效应,学术界提出了氮能神经的概念从而为我们深入了解非肾上腺素能非胆碱能神经开辟了全新的视角,同时也彰显出氮能神经在生物体中潜在的重大作用。本文将针氮能神经在胃、肠道、食管等主要消化道器官的分布情况、对消化道正常生理功能调控、以及与相关消化道疾病病理联系等方面展开综述,并设想了氮能神经可能基于一氧化氮合酶的各种异构体的相关性而在消化道正常、疾病两态之间的平衡机制中存在某种作用和联系。     

Current state of purification,isolation and analysis of bacteriocins produced by lactic acid bacteria

Applied Microbiology and Biotechnology - The scientific interest for the search of natural means of microbial inhibitors has not faded for several years. A search of natural antibiotics, so-called...